Showing results (71-80 of 190) with videos related to
Sort By:
Pageof 19
Annals of Hematology|December 6, 2003
Intravascular lymphoma associated with hemophagocytic syndrome: a rare but aggressive clinical entityNiyati S Bhagwati, Stanley J Oiseth, Lool S Abebe, et al.Leukemia & Lymphoma|October 31, 2006
Anticipation in families with Hodgkin's and non-Hodgkin's lymphoma in their pedigreeDoru T Alexandrescu, Alexandria Garino, Kelly A Brown-Balem, et al.Medical Oncology (Northwood, London, England)|December 17, 2002
Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin: a case reportGeorge Marcoullis, Lool Abebe, Dharamvir Jain, et al.Dermatology Online Journal|September 10, 2005
Unusually large colon cancer cutaneous and subcutaneous metastases occurring in resection scarsDoru T Alexandrescu, Juan Vaillant, Laura J Yahr, et al.Cancer|January 9, 2019
Association between age and sex and mortality after adjuvant therapy for renal cancerRonac Mamtani, Xin Victoria Wang, Bishal Gyawali, et al.Journal of Clinical Pharmacology|May 4, 2018
Core Entrustable Professional Activities in Clinical Pharmacology for Entering Residency: Value of Interprofessional Health-Care Teams in Medication Prescribing and Medication Error PreventionLawrence J Cohen, Vera S Donnenberg, Peter H Wiernik, et al.Journal for Immunotherapy of Cancer|September 25, 2019
High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014Janice P Dutcher, Douglas J Schwartzentruber, Howard L Kaufman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Clonal isolation of different strains of mouse mammary tumor virus-like DNA sequences from both the breast tumors and non-Hodgkin's lymphomas of individual patients diagnosed with both malignanciesPolly R Etkind, Alexandre F R Stewart, Thambi Dorai, et al.Urology|December 11, 2007
Renal medullary carcinoma: the Bronx experienceA Ari Hakimi, Phillip T Koi, Paul M Milhoua, et al.Medical Oncology (Northwood, London, England)|September 30, 2003
Stratification by risk factors predicts survival on the active treatment arm in a randomized phase II study of interferon-gamma plus/minus interferon-alpha in advanced renal cell carcinoma (E6890)Janice P Dutcher, Jason P Fine, Robert L Krigel, et al.Pageof 19